Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. sparktx.comSpark Therapeutics

   sparktx.com

   • Im Cache

   Our mission at Spark® Therapeutics is to unlock the power of gene therapy to accelerate healthcare transformation. We have built a fully integrated company, combining our proprietary adeno-associated viral (AAV) gene therapy platform with excellence in R&D, manufacturing and commercial operations.

2. sparktx.com › we-are-sparkWe Are Spark – Spark Therapeutics

   sparktx.com › we-are-spark

   • Im Cache

   At Spark Therapeutics, we’re working to unlock the power of gene therapy to accelerate healthcare transformation. Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), our investigational therapies have the potential to provide long-lasting effects ...

3. en.wikipedia.org › wiki › Spark_TherapeuticsSpark Therapeutics - Wikipedia

   en.wikipedia.org › wiki › Spark_Therapeutics

   • Im Cache

   Products and pipeline. The company has 3 gene therapy product candidates in clinical development: (i) SPK-8011, a candidate in the SPK-FVIII program for hemophilia A; (ii) SPK-8016, a product candidate for the hemophilia A inhibitor market; and (iii) SPK-7001, targeting choroideremia, or CHM.

4. www.roche.com › innovation › structureRoche | Spark

   www.roche.com › innovation › structure

   • Im Cache

   Spark Therapeutics was founded in 2013 and became a Member of the Roche Group in 2019. The organisation is a fully integrated, commercial company committed to discovering, developing and delivering gene therapies for genetic diseases, including inherited retinal disorders, haemophilia, lysosomal storage disorders and neurodegenerative diseases.

5. www.linkedin.com › company › spark-therapeutics-incSpark Therapeutics, Inc. | LinkedIn

   www.linkedin.com › company › spark-therapeutics-inc

   Spark Therapeutics, Inc. | 88,555 followers on LinkedIn. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation. | At Spark® Therapeutics, we believe in...

6. sparktx.com › press_releases › spark-therapeutics-announcesSpark Therapeutics Announces Departure of CEO and Founder Jeff...

   sparktx.com › press_releases › spark-therapeutics-announces

   • Im Cache

   23. Feb. 2022 · Spark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo; COO Ron Philip Named as Successor. Under Jeff Marrazzo’s leadership, Spark launched world’s first FDA-approved gene therapy for a genetic disease. He also spearheaded Spark’s $4.8 billion acquisition by Roche.

7. finance.yahoo.com › news › spark-therapeutics-announcesSpark Therapeutics Announces Updated Phase 1/2 Study Results...

   finance.yahoo.com › news › spark-therapeutics-announces

   • Im Cache

   12. Dez. 2022 · Spark Therapeutics, Inc. Multi-year data, with up to five years of follow up, show sustained expression of FVIII in more than 90% of participants, in addition to improved annual bleeding and...